Delivery Order SPE2DB24D1205-SPE2DB24FCUDY

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the procurement of a specific pharmaceutical product, ONFI 10 MG TABLET 100S. The contract has a ceiling value of $4,310.34 and a completion date of January 15, 2025. The contract is a firm-fixed-price delivery order, with no set-aside requirement indicated. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONFI 10 MG TABLET 100S, with a ceiling value of $3,683.44 and a completion date of June 11, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,707.35 firm-fixed-price contract is for the supply of ONFI 10 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by DLA and other federal agencies, valued up to $999,999,999, to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,374.45, is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,564,575 ONFI 10 MG TABLET 100S. The contract has a ceiling value of $4,960.15 and a completion date of August 26, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ONFI 10 MG TABLET 100S. The contract has a ceiling value of $6,318.25 and a period of performance through June 16, 2025. It is a firm fixed-price contract, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,795.48, is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) contract, with a period of performance through June 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,550.46, is for the delivery of 4567136881 ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of February 4, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $3,336.16 firm fixed price contract is for the supply of 4565243489 ONFI 10 MG TABLET 100S, which are pharmaceutical products. The delivery order has a completion date of July 25, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical and medical products to various federal...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $7,802.53, is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 3, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a significant...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCUDY
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of pharmaceutical products, specifically ONFI 10 MG TABLET 100S. The contract has a ceiling value of $2,413.85 and an ultimate completion date of August 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these products under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/27/24, 9:30 AM